| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 19:03:59 UTC |
|---|
| Update Date | 2021-09-26 23:14:32 UTC |
|---|
| HMDB ID | HMDB0257918 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | (2S)-6-Hydroxy-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecanoyl]-3,4-dihydrochromene-5-carbaldehyde |
|---|
| Description | (2S)-6-Hydroxy-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecanoyl]-3,4-dihydrochromene-5-carbaldehyde belongs to the class of organic compounds known as tocopherols. These are vitamin E derivatives containing a saturated trimethyltridecyl chain attached to the carbon C6 atom of a benzopyran ring system. The differ from tocotrienols that contain an unsaturated trimethyltrideca-3,7,11-trien-1-yl chain. Based on a literature review very few articles have been published on (2S)-6-Hydroxy-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecanoyl]-3,4-dihydrochromene-5-carbaldehyde. This compound has been identified in human blood as reported by (PMID: 31557052 ). (2s)-6-hydroxy-2,7,8-trimethyl-2-[(4r,8r)-4,8,12-trimethyltridecanoyl]-3,4-dihydrochromene-5-carbaldehyde is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (2S)-6-Hydroxy-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecanoyl]-3,4-dihydrochromene-5-carbaldehyde is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CC(C)CCCC(C)CCCC(C)CCC(=O)C1(C)CCC2=C(C=O)C(O)=C(C)C(C)=C2O1 InChI=1S/C29H46O4/c1-19(2)10-8-11-20(3)12-9-13-21(4)14-15-26(31)29(7)17-16-24-25(18-30)27(32)22(5)23(6)28(24)33-29/h18-21,32H,8-17H2,1-7H3 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C29H46O4 |
|---|
| Average Molecular Weight | 458.683 |
|---|
| Monoisotopic Molecular Weight | 458.339609961 |
|---|
| IUPAC Name | 6-hydroxy-2,7,8-trimethyl-2-(4,8,12-trimethyltridecanoyl)-3,4-dihydro-2H-1-benzopyran-5-carbaldehyde |
|---|
| Traditional Name | 6-hydroxy-2,7,8-trimethyl-2-(4,8,12-trimethyltridecanoyl)-3,4-dihydro-1-benzopyran-5-carbaldehyde |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC(C)CCCC(C)CCCC(C)CCC(=O)C1(C)CCC2=C(C=O)C(O)=C(C)C(C)=C2O1 |
|---|
| InChI Identifier | InChI=1S/C29H46O4/c1-19(2)10-8-11-20(3)12-9-13-21(4)14-15-26(31)29(7)17-16-24-25(18-30)27(32)22(5)23(6)28(24)33-29/h18-21,32H,8-17H2,1-7H3 |
|---|
| InChI Key | RSJKCJWTVLBIAG-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as tocopherols. These are vitamin E derivatives containing a saturated trimethyltridecyl chain attached to the carbon C6 atom of a benzopyran ring system. The differ from tocotrienols that contain an unsaturated trimethyltrideca-3,7,11-trien-1-yl chain. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Prenol lipids |
|---|
| Sub Class | Quinone and hydroquinone lipids |
|---|
| Direct Parent | Tocopherols |
|---|
| Alternative Parents | |
|---|
| Substituents | - Tocopherol
- Diterpenoid
- Chromane
- Benzopyran
- 1-benzopyran
- Alkyl aryl ether
- Phenol
- Aryl-aldehyde
- Benzenoid
- Vinylogous acid
- Ketone
- Organoheterocyclic compound
- Ether
- Oxacycle
- Organooxygen compound
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Aldehyde
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 9.42 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 34.1622 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 0.88 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 4006.3 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 1099.0 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 409.6 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 579.8 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 821.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1802.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1608.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 115.8 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 2979.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 1021.9 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 3019.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1051.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 781.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 716.7 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 880.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 9.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized| Metabolite | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| (2S)-6-Hydroxy-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecanoyl]-3,4-dihydrochromene-5-carbaldehyde | CC(C)CCCC(C)CCCC(C)CCC(=O)C1(C)CCC2=C(C=O)C(O)=C(C)C(C)=C2O1 | 3587.1 | Standard polar | 33892256 | | (2S)-6-Hydroxy-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecanoyl]-3,4-dihydrochromene-5-carbaldehyde | CC(C)CCCC(C)CCCC(C)CCC(=O)C1(C)CCC2=C(C=O)C(O)=C(C)C(C)=C2O1 | 3278.9 | Standard non polar | 33892256 | | (2S)-6-Hydroxy-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecanoyl]-3,4-dihydrochromene-5-carbaldehyde | CC(C)CCCC(C)CCCC(C)CCC(=O)C1(C)CCC2=C(C=O)C(O)=C(C)C(C)=C2O1 | 3363.9 | Semi standard non polar | 33892256 |
Derivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| (2S)-6-Hydroxy-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecanoyl]-3,4-dihydrochromene-5-carbaldehyde,2TMS,isomer #1 | CC1=C(C)C2=C(CCC(C)(C(=CCC(C)CCCC(C)CCCC(C)C)O[Si](C)(C)C)O2)C(C=O)=C1O[Si](C)(C)C | 3277.3 | Semi standard non polar | 33892256 | | (2S)-6-Hydroxy-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecanoyl]-3,4-dihydrochromene-5-carbaldehyde,2TMS,isomer #1 | CC1=C(C)C2=C(CCC(C)(C(=CCC(C)CCCC(C)CCCC(C)C)O[Si](C)(C)C)O2)C(C=O)=C1O[Si](C)(C)C | 3160.2 | Standard non polar | 33892256 | | (2S)-6-Hydroxy-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecanoyl]-3,4-dihydrochromene-5-carbaldehyde,2TMS,isomer #1 | CC1=C(C)C2=C(CCC(C)(C(=CCC(C)CCCC(C)CCCC(C)C)O[Si](C)(C)C)O2)C(C=O)=C1O[Si](C)(C)C | 3409.9 | Standard polar | 33892256 | | (2S)-6-Hydroxy-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecanoyl]-3,4-dihydrochromene-5-carbaldehyde,2TBDMS,isomer #1 | CC1=C(C)C2=C(CCC(C)(C(=CCC(C)CCCC(C)CCCC(C)C)O[Si](C)(C)C(C)(C)C)O2)C(C=O)=C1O[Si](C)(C)C(C)(C)C | 3775.1 | Semi standard non polar | 33892256 | | (2S)-6-Hydroxy-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecanoyl]-3,4-dihydrochromene-5-carbaldehyde,2TBDMS,isomer #1 | CC1=C(C)C2=C(CCC(C)(C(=CCC(C)CCCC(C)CCCC(C)C)O[Si](C)(C)C(C)(C)C)O2)C(C=O)=C1O[Si](C)(C)C(C)(C)C | 3487.8 | Standard non polar | 33892256 | | (2S)-6-Hydroxy-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecanoyl]-3,4-dihydrochromene-5-carbaldehyde,2TBDMS,isomer #1 | CC1=C(C)C2=C(CCC(C)(C(=CCC(C)CCCC(C)CCCC(C)C)O[Si](C)(C)C(C)(C)C)O2)C(C=O)=C1O[Si](C)(C)C(C)(C)C | 3560.4 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - (2S)-6-Hydroxy-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecanoyl]-3,4-dihydrochromene-5-carbaldehyde GC-MS (Non-derivatized) - 70eV, Positive | splash10-030c-6895400000-f10036d9b08e43ab0a60 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (2S)-6-Hydroxy-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecanoyl]-3,4-dihydrochromene-5-carbaldehyde GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (2S)-6-Hydroxy-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecanoyl]-3,4-dihydrochromene-5-carbaldehyde GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (2S)-6-Hydroxy-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecanoyl]-3,4-dihydrochromene-5-carbaldehyde GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (2S)-6-Hydroxy-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecanoyl]-3,4-dihydrochromene-5-carbaldehyde GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (2S)-6-Hydroxy-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecanoyl]-3,4-dihydrochromene-5-carbaldehyde GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
|
|---|